ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹990 Cr | ₹732 Cr | ₹753 Cr | ₹801 Cr | ₹656 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹990 Cr |
| Mar2025 | ₹732 Cr |
| Mar2024 | ₹753 Cr |
| Mar2023 | ₹801 Cr |
| Mar2022 | ₹656 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹990 Cr | 35.27 | |
| Mar2025 | ₹732 Cr | -2.84 | |
| Mar2024 | ₹753 Cr | -5.98 | |
| Mar2023 | ₹801 Cr | 22.19 | |
| Mar2022 | ₹656 Cr | - | |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹109,824.8 Cr | -1.4% | -0.7% | 13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | -1.4% |
-0.7% |
13.5% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses